Form 4: Generation Bio Co. Executive Yalonda Howze Reports Stock Transactions
SEC Form 4 Filing
Yalonda Howze, Chief Legal Officer of Generation Bio Co., reports the vesting and subsequent disposal of restricted stock units.
Summary
- On July 15, 2024, Yalonda Howze, the Chief Legal Officer of Generation Bio Co., reported transactions involving the company's common stock.
- These transactions included the vesting of 3,347 restricted stock units and the disposal of 983 shares to cover tax obligations at a price of $2.93 per share.
- Following these transactions, Howze directly owns 11,822 shares of common stock and 36,815 restricted stock units.
- The restricted stock units vest over four years, with 25% vesting on April 15, 2024, and the remaining shares vesting in equal quarterly installments thereafter.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing reflecting standard compensation practices. It doesn't inherently indicate positive or negative sentiment regarding the company's performance.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's stock. It's a standard practice for executives to receive and vest stock options or restricted stock units as part of their compensation packages.
Comparison to Industry Standards
- Form 4 filings are standard practice across all publicly traded companies, including biotechnology firms like Generation Bio Co.
- The vesting schedule of the restricted stock units (25% after one year, then quarterly) is a common vesting structure.
- Comparable companies such as CRISPR Therapeutics, Editas Medicine, and Intellia Therapeutics also have executives who regularly file Form 4s to report stock transactions.
Stakeholder Impact
- The transactions reported in this filing have a minimal direct impact on shareholders, employees, customers, suppliers, and creditors.
- The filing provides transparency regarding insider transactions, which can be useful for shareholders.
Key Dates
| Date | Description |
|---|---|
| April 5, 2023 | Grant date of 53,550 restricted stock units. |
| April 15, 2024 | 25% of the restricted stock units vested. |
| July 15, 2024 | Vesting of 3,347 restricted stock units and disposal of 983 shares for tax obligations. |
| July 17, 2024 | Date of the Attorney-in-Fact signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.